We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

156 hedge funds and large institutions have $202M invested in Amneal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.51% more ownership

Funds ownership: 65.78% → 67.29% (+1.5%)

1% more funds holding

Funds holding: 154 → 156 (+2)

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more capital invested

Capital invested by funds: $200M → $202M (+$2.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less call options, than puts

Call options by funds: $119K | Put options by funds: $149K

Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
48
Reduced
47
Closed
27
Calls
$119K
Puts
$149K
Net Calls
-$30K
Net Calls Change
+$656K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$8.55M
2
Millennium Management
Millennium Management
New York
+$6.8M
3
Norges Bank
Norges Bank
Norway
+$6.08M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$2.61M
5
Bank of America
Bank of America
North Carolina
+$1.96M

Top Sellers

1
TGA
TPG GP A
Texas
-$8.71M
2
EP
Eversept Partners
New York
-$8.65M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.55M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
5
JAM
Jupiter Asset Management
United Kingdom
-$1.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
151
PNC Financial Services Group
Pennsylvania
$398 – – –
LC
152
Lindbrook Capital
California
$155 -$74 -33 -30%
NSIM
153
North Star Investment Management
Illinois
$119 – – –
SVCP
154
Silicon Valley Capital Partners
California
$60 +$67 +30 New
PAG
155
Private Advisor Group
New Jersey
$50 +$56.5K +25,200 New
Point72 Asset Management
156
Point72 Asset Management
Connecticut
– -$5.55M -2,750,000 Closed
JAM
157
Jupiter Asset Management
United Kingdom
– -$1.98M -979,648 Closed
HIM
158
Hillsdale Investment Management
Ontario, Canada
– -$1.74M -861,716 Closed
BGIM
159
Brandywine Global Investment Management
Pennsylvania
– -$381K -188,559 Closed
PP
160
PDT Partners
New York
– -$138K -68,449 Closed
SG Americas Securities
161
SG Americas Securities
New York
– -$126K -62,243 Closed
JF
162
Jump Financial
Illinois
– -$105K -52,300 Closed
MA
163
Montag & Associates
Georgia
– -$81K -40,000 Closed
Truist Financial
164
Truist Financial
North Carolina
– -$50K -24,896 Closed
VF
165
Virtu Financial
New York
– -$44K -21,605 Closed
E
166
Ergoteles
New York
– -$36K -17,759 Closed
GCM
167
Gladius Capital Management
Illinois
– -$34K -16,596 Closed
CIBC Asset Management
168
CIBC Asset Management
Ontario, Canada
– -$29K -14,567 Closed
PTC
169
Petrus Trust Company
Texas
– -$26K -12,652 Closed
TI
170
Tidal Investments
Wisconsin
– -$21K -10,540 Closed
RPCA
171
Running Point Capital Advisors
California
– -$20K -10,000 Closed
PHK
172
Point72 Hong Kong
Hong Kong
– -$18K -8,823 Closed
Acadian Asset Management
173
Acadian Asset Management
Massachusetts
– -$15K -7,618 Closed
AF
174
Allworth Financial
California
– -$13K -6,365 Closed
ACM
175
Aquatic Capital Management
Illinois
– -$7K -3,300 Closed
4 5 6
7
8

AMRX Hedge Fund Activity: Q4 2022 in Review

156 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2022, worth a combined $202M — up 1.2% from $200M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AMRX positions and 27 closed out — a net gain of 2 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $8.55M. The largest seller was TPG GP A, cutting an estimated $8.71M.

  • 156 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2022, up from 154 in Q3 2022.
  • Funds reported $202M of Amneal Pharmaceuticals stock for Q4 2022, up 1.2% quarter-over-quarter.
  • 29 funds opened new Amneal Pharmaceuticals positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2022 was Morgan Stanley, an estimated $8.55M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2022 was TPG GP A, an estimated $8.71M sold.

Based on aggregated 13F filings for Q4 2022.